Exploring Ozempic treatment
Canonical GLP-1RAs, such as liraglutide, semaglutide, and tirzepatide (which possesses dual GLP-1/GIP receptor agonist activity), have consistently demonstrated superior metabolic and cardiorenal outcome benefits in large-scale randomized controlled trials (RCTs) ( Regarding weight reduction, pooled results from clinical trials indicate that, compared to placebo, liraglutide at 3.0 mg/d achieves a placebo-subtracted weight loss of approximately 5%
Both GLP-1RAs and tirzepatide demonstrated efficacy in improving circulatory lipid profiles in the large clinical trials (199, 200)
AMPK is a systemic enzyme that influences how the body creates and uses cellular energy.* Ideal for maintaining balanced and overall metabolic wellness.*
Not chasing trends blindly, but choosing treatments that are medically guided, personalised, and realistic
66 LiC.ZhengY.XiongX.XueF